Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.66 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.51 |
| ▸ | RAD52 | P43351 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 2/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | FAAH | O00519 | 2/20 | 0.50 |
| ▸ | DGKA | P23743 | 1/20 | 0.50 |
| ▸ | HTR2C | P28335 | 1/20 | 0.49 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.44 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.44 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.44 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2231096 | 1.00 | NAAA (0.66) | NAAANPSR1RAD52MAPTMAPK1 | |
| SCHEMBL1055187 | 1.00 | NAAA (0.66) | NAAANPSR1RAD52MAPTMAPK1 | |
| SCHEMBL1053266 | 1.00 | NAAA (0.66) | NAAANPSR1RAD52MAPTMAPK1 | |
| SCHEMBL33595 | 1.00 | NAAA (0.66) | NAAANPSR1RAD52MAPTMAPK1 | |
| SCHEMBL9099483 | 1.00 | NAAA (0.66) | NAAANPSR1RAD52MAPTMAPK1 | |
| SCHEMBL9242191 | 1.00 | NAAA (0.66) | NAAANPSR1RAD52MAPTMAPK1 | |
| SCHEMBL9099743 | 1.00 | NAAA (0.66) | NAAANPSR1RAD52MAPTMAPK1 | |
| SCHEMBL3911129 | 1.00 | NAAA (0.66) | NAAANPSR1RAD52MAPTMAPK1 | |
| SCHEMBL749593 | 1.00 | NAAA (0.66) | NAAANPSR1RAD52MAPTMAPK1 | |
| SCHEMBL8416064 | 1.00 | NAAA (0.66) | NAAANPSR1RAD52MAPTMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115916149-A | Cosmetic composition comprising a polyhydroxyalkanoate copolymer comprising at least two different polymer units with (un) saturated hydrocarbyl chains in a fatty medium | 莱雅公司 | 2023-04-04 | — | — | CN | claimed |
| CN-115916144-A | Cosmetic composition comprising a polyhydroxyalkanoate copolymer with a (non) saturated hydrocarbyl chain and a surfactant | 莱雅公司 | 2023-04-04 | — | — | CN | claimed |
| CN-115835855-A | Cosmetic composition comprising a graft polyhydroxyalkanoate copolymer in a fatty medium | 莱雅公司 | 2023-03-21 | — | — | CN | claimed |
| CN-108486293-A | A kind of preparation method of polymer leather fatting agent | 齐河力厚化工有限公司 | 2018-09-04 | — | — | CN | claimed |
| CN-108342525-A | A kind of modified silicon oil leather fat | 齐河力厚化工有限公司 | 2018-07-31 | — | — | CN | claimed |
| CN-107109177-A | Reactive polyurethane-hot melt adhesive and application thereof | 汉高股份有限及两合公司 | 2017-08-29 | — | — | CN | claimed |
| EP-4724531-A1 | THERMOPLASTIC COMPOSITION, ARTICLES PREPARED THEREFROM, AND METHOD FOR THE MANUFACTURE THEREOF | SHPP Global Technologies B.V. (NL) | 2026-04-15 | — | — | EP | disclosed |
| US-12577373-B2 | Carbodiimide composition, curing agent composition, coating composition and resin cured product | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2026-03-17 | — | — | US | disclosed |
| WO-2024252351-A1 | THERMOPLASTIC COMPOSITION, ARTICLES PREPARED THEREFROM, AND METHOD FOR THE MANUFACTURE THEREOF | SHPP GLOBAL TECHNOLOGIES B.V. (NL) | 2024-12-12 | — | — | WO | disclosed |
| WO-2024224178-A1 | COMPOSITION, METHOD FOR THE MANUFACTURE THEREOF, AND ARTICLES COMPRISING THE COMPOSITION | SHPP GLOBAL TECHNOLOGIES B.V. (NL) | 2024-10-31 | — | — | WO | disclosed |
| EP-4455197-A1 | COMPOSITION, METHOD FOR THE MANUFACTURE THEREOF, AND ARTICLES COMPRISING THE COMPOSITION | SHPP Global Technologies B.V. (NL) | 2024-10-30 | — | — | EP | disclosed |
| US-20240351957-A1 | ADMIXTURE TO CONTROL THE HEAT FLOW FROM MINERAL BINDER COMPOSITIONS, MINERAL BINDER COMPOSITIONS, AND PRODUCTION METHOD THEREOF | SIKA TECHNOLOGY AG (CH) | 2024-10-24 | — | — | US | disclosed |
| EP-4446310-A1 | METHOD FOR PRODUCING BLOCKED ISOCYANATE COMPOUND AND METHOD FOR PRODUCING ISOCYANATE COMPOUND | Asahi Kasei Kabushiki Kaisha (JP) | 2024-10-16 | — | — | EP | disclosed |
| US-5379058-A | Recording apparatus using a thermosensitive recording medium | RICOH COMPANY, LTD. (JP) | 1995-01-03 | — | — | US | disclosed |
| US-5139807-A | Replacements for fats and oils in foods | NABISCO, INC. (US) | 1992-08-18 | — | — | US | disclosed |
| US-5068119-A | Dietetics with fat substitutes | NABISCO BRANDS, INC. (US) | 1991-11-26 | — | — | US | disclosed |
| US-5064678-A | Linked Esters | NABISCO BRANDS, INC. (US) | 1991-11-12 | — | — | US | disclosed |
| US-4963386-A | MULTI-ESTER COMPOUNDS | NABISCO BRANDS, INC. (US) | 1990-10-16 | — | — | US | disclosed |
| WO-1989001293-A1 | LOW CALORIE FAT MIMETICS COMPRISING CARBOXY/CARBOXYLATE ESTERS | NABISCO BRANDS, INC. (US) | 1989-02-23 | — | — | WO | disclosed |
| EP-0303523-A1 | Low calorie fat mimetics comprising carboxy/carboxylate esters | NABISCO, INC. (US) | 1989-02-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12577373-B2 | Carbodiimide composition, curing agent composition, coating composition and resin cured product | CD38, PARP9, MCCC2 | NAAA 757/4885NPSR1 4881/4885RAD52 1397/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.